Recent evidence suggests that ghrelin may also be neuroprotective after injury in animal models of cerebral ischemia. Thus exogenous ghrelin treatment can improve cell survival, reduce infarct size, and rescue memory deficits in focal ischemia models, doing so by suppressing inflammation and apoptosis. Endogenous ghrelin plays a key a role in a number of physiological processes, including feeding, metabolism, stress, and anxiety. However, no study has examined whether endogenous ghrelin also contributes to neuroprotection after cerebral ischemia. Here, we aimed to determine whether endogenous ghrelin normally protects against neuronal cell death and cognitive impairments after global cerebral ischemia and whether such changes are linked with inflammation or apoptosis. We used a two-vessel occlusion (2VO) model of global cerebral ischemia in wild-type (wt) and ghrelin knockout (ghrϪ/Ϫ) C57/Bl6J mice. ghrϪ/Ϫ mice had improved cell survival in the Cornu Ammonis(CA)-2/3 region of the hippocampus-a region of significant growth hormone secretagogue receptor expression. They also displayed less cellular degeneration than wt mice after the 2VO (Fluoro-Jade) and had less cognitive impairment in the novel object-recognition test. These outcomes were despite evidence of more neuroinflammation and apoptosis in the ghrϪ/Ϫ and less of a postsurgery hypothermia. Finally, we found that mortality in the week following the 2VO was reduced more in ghrϪ/Ϫ mice than in wt. Overall, these experiments point to a neurodegenerative but antiapoptotic effect of endogenous ghrelin in this model of global ischemia, highlighting that further research is essential before we can apply ghrelin treatments to neurodegenerative insults in the clinic. ghrelin; two-vessel occlusion; neurodegeneration; stroke; ghrelin knockout SINCE THE FIRST DESCRIPTION of ghrelin in 1999 as a growth hormone secretagogue (34), a number of functions have been attributed to this 28 amino acid gastrointestinal peptide, including in feeding, metabolism, reward, and stress (1, 15, 17, 46, 50, 67, 71) . More recently, treatment with exogenous ghrelin has been reported in a variety of animal models of neurodegenerative disease to prevent apoptosis and improve cell survival and cognitive function. For instance, in the 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP) model of Parkinson's disease (PD), exogenous ghrelin prevents apoptosis and reactive oxygen species production and improves survival of the dopamine cells in the substantial nigra pars compacta and striatum (3, 31, 45) . In models of Alzheimer's disease (AD), ghrelin treatment prevents amyloid ␤ oligomer-induced hippocampal cell death and cognitive decline (44). Ghrelin treatment is also neuroprotective in animal models of focal ischemia-reperfusion. Thus exogenous ghrelin reduces infarct size and hippocampal and cortical cell death and improves memory and learning in this model. Evidence suggests that ghrelin mediates this neuroprotection principally by suppressing neuroinflammation and limiting apoptosis (6, 40, 43) . These observations are encouraging from the perspective of potentially applying exogenous ghrelin as a therapeutic treatment against neurodegeneration after human stroke. These findings also lead to the possibility that endogenous ghrelin can protect the brain after ischemic injury. Enhancing endogenous ghrelin levels may therefore prove to be a valuable neuroprotective strategy, but we currently know little about its role.
SINCE THE FIRST DESCRIPTION of ghrelin in 1999 as a growth hormone secretagogue (34), a number of functions have been attributed to this 28 amino acid gastrointestinal peptide, including in feeding, metabolism, reward, and stress (1, 15, 17, 46, 50, 67, 71) . More recently, treatment with exogenous ghrelin has been reported in a variety of animal models of neurodegenerative disease to prevent apoptosis and improve cell survival and cognitive function. For instance, in the 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP) model of Parkinson's disease (PD), exogenous ghrelin prevents apoptosis and reactive oxygen species production and improves survival of the dopamine cells in the substantial nigra pars compacta and striatum (3, 31, 45) . In models of Alzheimer's disease (AD), ghrelin treatment prevents amyloid ␤ oligomer-induced hippocampal cell death and cognitive decline (44) . Ghrelin treatment is also neuroprotective in animal models of focal ischemia-reperfusion. Thus exogenous ghrelin reduces infarct size and hippocampal and cortical cell death and improves memory and learning in this model. Evidence suggests that ghrelin mediates this neuroprotection principally by suppressing neuroinflammation and limiting apoptosis (6, 40, 43) . These observations are encouraging from the perspective of potentially applying exogenous ghrelin as a therapeutic treatment against neurodegeneration after human stroke. These findings also lead to the possibility that endogenous ghrelin can protect the brain after ischemic injury. Enhancing endogenous ghrelin levels may therefore prove to be a valuable neuroprotective strategy, but we currently know little about its role.
Evidence now suggests that endogenous circulating ghrelin is lower after stroke in human sufferers (32). In experimental models, the receptor for the acylated form of ghrelin [growth hormone secretagogue receptor (GHSR)] is reduced in the brain after ischemia-reperfusion injury (43) , and receptor expression can be increased by exogenous ghrelin treatment (43) . At least one study has shown that the neuroprotective effect of exogenous ghrelin treatment is absent in ad libitum-fed animals and only occurs when the mice are fasted (and endogenous ghrelin is presumably high) (3) . Collectively, these studies suggest restoring ghrelin levels, or levels/activity of the receptor may counteract the effects of a neurodegenerative insult. In addition, the GHSR has significant constitutive activity that may contribute to as much as 50% of signaling in the absence of the ligand (51) . Thus even if endogenous ghrelin levels are low, the constitutive activity of GHSR may confer neuroprotection.
In this investigation, we aimed to determine the role of endogenous ghrelin in neuroprotection after an ischemic-reperfusion injury that causes significant cell death in the hippocampus (11) . We aimed to 1) determine whether endogenous ghrelin normally protects against the neuronal cell death and cognitive impairments associated with ischemia and 2) determine whether such changes are associated with neuroinflammation and apoptosis. We used a model of global cerebral ischemia [two-vessel occlusion (2VO)] in wild-type (wt) and ghrelin knockout (ghrϪ/Ϫ) C57/Bl6J mice, and we hypothesized that the absence of endogenous ghrelin in the ghrϪ/Ϫ would exacerbate neuronal injury after the 2VO.
MATERIALS AND METHODS

Animals
We conducted all experiments in accordance with the National Health and Medical Research Council Australia Code of Practice for the Care of Experimental Animals. All experiments were approved by the Monash University School of Biomedical Sciences Animal Ethics Committee.
We obtained ghrϪ/Ϫ mice (on a C57/Bl6J background) from Regeneron Pharmaceuticals (Tarrytown, NY) and bred them in the Monash Animal Services facility. Our ghrϪ/Ϫ mice were obtained originally from Regeneron Pharmaceuticals in 2008. They were rederived in our facility at Monash University and then backcrossed onto C57/Bl6J mice for at least 10 generations. They therefore exhibit a C57/Bl6J genetic profile. This backcrossing procedure has been described previously (68) . From these heterozygous pairs, we generated six to eight breeding pairs of ghrϪ/Ϫ and six to eight of ghrϩ/ϩ. Each pair breeds experimental animals for ϳ6 mo, during which time, new pairs of F2 ghrϪ/Ϫ and ghrϩ/ϩ are mated to generate heterozygous mice. These heterozygous mice are subsequently mated to generate wt and ghrϪ/Ϫ, which are then used for new breeding pairs. There is therefore no likelihood of genetic divergence in our lines. The ghrϪ/Ϫ mice have been validated and published in numerous journals [e.g., refs. (1, 19, 68, 74, 75) ]. We have also verified independently they do not produce ghrelin (25). Our group has published several manuscripts using this rederived and backcrossed genetic strain (25, 61). We also routinely genotype all of our mice. Briefly, PCR was used to screen genotypes using DNA isolated from mouse tail biopsy samples. The four primers, TCATCTGTCCTCACCACCAA, AGT-AGCCTGAAAAGCCAGCA, ACGGGTTGTTACTCGCTCAC, and CATAACTGCCGTCACTCCAAC, were used to amplify a 431-bp band from the wt allele and a 232-bp band from the knockout allele. Heterozygotes had two bands (at 232 bp and 431 bp). The GHSRgreen fluorescence protein (gfp) mice were obtained from the Mouse Mutant Regional Resource Center at the University of California at Davis (Davis, CA). This mouse was generated by the Gene Expression Nervous System Atlas project at The Rockefeller University (New York, NY) and contains a modified bacterial artificial chromosome, in which a gfp reporter is inserted immediately upstream of the coding sequence for the GHSR gene. We (3, 67) and others (74) have also described this mouse line previously. Mice were maintained at 22°C on a 12-h light/dark cycle (0700 -1900) with pelleted mouse chow and water available ad libitum. We conducted all experiments using adult male wt or ghrϪ/Ϫ mice of 8 -10 wk.
Surgery
We performed sham or 2VO surgery on wt and ghrϪ/Ϫ mice, as we have described previously in rats, except that hypotension was not maintained (62, 64, 66) . This 2VO surgery has also been described in mice by other groups (27, 36). Briefly, we anesthetized the mice with isofluorane (induced at 4% in a Plexiglas chamber and maintained at 2% by means of a face mask). During surgery, we estimated core temperature using a thermocouple rectal thermometer and maintained it between 35°C and 37°C using fine adjustments of an overhead heating lamp. To induce global ischemia, we made a ventral midline neck incision to expose the common carotid arteries. We then occluded both common carotid arteries simultaneously for 20 min with nontraumatic microarterial clips. We identified a 20-min duration of carotid artery occlusion in preliminary trials as necessary and sufficient to produce consistent neuronal cell damage in the hippocampus, with one region particularly vulnerable to ischemic damage in this model (12, 53, 58, 59) . After the clips were removed, we visually inspected the arteries to ensure reperfusion. We performed the same surgery in sham-treated animals but made no occlusion of the arteries. At the conclusion of the 2VO surgery, we also implanted preprogrammed temperature monitors (SubCue Dataloggers, Calgary, Alberta, Canada) into the peritoneal cavity of the mice. Immediately after surgery, we returned the animals to their home cages and allowed them to recover undisturbed for 24 h, except as described below.
Behavioral Testing
To examine cognitive deficits after the 2VO, we conducted a novel object-recognition test for nonspatial working memory (65) . We did these tests prior to and 24 h after the surgery. We initially gave each mouse 15 min to explore an open-field arena (30 ϫ 45 ϫ 30 cm) before introducing two identical objects. The mouse explored these identical objects for a further 15 min, was given a 30-min intertrial interval, and was then returned to the arena for 5 min with one familiar object and one new one. Each recognition trial was videotaped and scored for time spent in the zone surrounding each object using Ethovision software (EthoVision XT; Noldus Information Technology, Wageningen, The Netherlands). From the scores, we calculated a discrimination ratio (time spent exploring the novel object/total object interaction time), with a ratio Ͻ0.5 indicating memory deficit. The arena was thoroughly cleaned with 70% ethanol between trials.
Perfusions
At 24 h postsurgery (immediately after behavioral testing), we deeply anesthetized the mice with 5% isofluorane and perfused them with PBS (4°C; pH 7.4) via the left cardiac ventricle, followed by 4% paraformaldehyde in PBS (4°C; pH 7.4). We removed the brains and postfixed them for 24 h in the same fixative before placing them in a cryoprotectant of 20% sucrose in PBS (4°C). Forebrains were subsequently cut using a cryostat into 20-m coronal sections.
Histology
We quantified the extent of ischemic injury by histological analysis of remaining hippocampal neurons in 20-m cresyl violet-stained coronal sections. An experimenter, blinded to the mouse's genotype and surgery group, evaluated neuronal survival in the Cornu Ammonis (CA)1 and CA2/3 subfields of the hippocampus across three 20-m sections, 200-m apart from and caudal to Ϫ1.58 mm, relative to bregma. The three values obtained for each subfield of the hippocampus were summed to obtain a sampled total for each region. We also quantified numbers of degenerating cells by analysis of Fluoro-Jadestained CA1 and CA2/3 hippocampal sections adjacent to those used for cresyl violet.
Immunohistochemistry
Sections adjacent to those used for Fluoro-Jade were immunolabeled for caspase-3 (a marker of apoptosis), ionized calcium-binding adapter molecule-1 (Iba-1; a marker for microglia/macrophages), or glial fibrillary acidic protein (GFAP; a marker for astrocytes). Briefly, sections for caspase-3 were incubated in active casapse-3 antibody (overnight; 4°C; 1:1,000; Abcam, Cambridge, UK), followed by secondary antibody (90 min; 1:400; goat anti-rabbit; Jackson ImmunoResearch Laboratories, West Grove, PA), and visualized using mounting medium containing 4=,6-diamidino-2-phenylindole (DAPI; Vectashield; Vector Laboratories, Burlingame, CA). Sections for Iba-1 were incubated in primary Iba-1 antibody (overnight; 4°C; 1:1,000; rabbit; Wako Chemicals USA, Richmond, VA), followed by secondary antibody (2 h; 1:200; biotinylated anti-rabbit; Vector Laboratories), and an avidin-biotin horseradish peroxidase (HRP) complex (1 h; Vectastain Elite ABC Kit; Vector Laboratories). Sections for GFAP were incubated in primary GFAP antibody (overnight; 4°C; 1:1,000; rabbit; Dako, Glostrup, Denmark), followed by secondary antibody (2 h; 1:200; biotinylated anti-rabbit; Vector Laboratories), and a HRP complex (1 h; Vectastain Elite ABC Kit; Vector Laboratories). The sections were then incubated in diaminobenzidine to visualize the HRP activity, seen as brown staining. The reactions were terminated once an optimal contrast between specific cellular and nonspecific background labeling was reached. Sections from each treatment group were processed simultaneously. Sections were mounted on polylysine-coated slides, dehydrated in a series of alcohols, cleared in xylene, and coverslipped.
An experimenter, blinded to the mouse's treatment group, evaluated total numbers of caspase-3, Iba-1, and GFAP-positive cells in the CA1 and CA2/3 using the same counting procedure as for the histology. Activated microglia were distinguished from inactive by their shorter, less-ramified processes, perikaryal hypertrophy, and ameboid appearance.
To demonstrate patterns of GHSR expression, sections from the GHSR-gfp mice were incubated in primary enhanced gfp antibody (overnight; 4°C; 1:1,000; chicken; Abcam), followed by secondary antibody (2 h; 1:200; goat anti-chicken; Alexa Fluor 488; Invitrogen, Carlsbad, CA), and visualized using mounting medium (Vectashield; Vector Laboratories).
Data Analysis
In these experiments, we used n ϭ 8/group in the 24-h recovery cohort. A second group (2VO only) was allowed to recover for 7 days (n ϭ 11 2VO wt, and n ϭ 12 2VO ghrϪ/Ϫ). We compared all behavioral and histological scores for the 24-h group using 2 ϫ 2 between-group ANOVA with genotype (wt and ghrϪ/Ϫ) and surgery (sham and 2VO) as between factors, followed by one-way ANOVA with Student-Newman-Keuls post hocs as appropriate. Temperature data were used to derive a temperature index (°C ϫ hour), as we have described previously (9, 63) for the 24 h after surgery. That is, the temperatures at each 10-min interval were averaged over the first 30 min to calculate a baseline for each period. The mean change from this baseline was then calculated per hour for each animal, and these data were summed as appropriate to produce an "area-under-the-curve" value (temperature index). Temperature indices were then compared using a Student's unpaired t-test. We also analyzed these data using a two-way ANOVA, with time as the repeated measure within factor. All data were assessed for homogeneity of variance and transformations applied where appropriate. Statistical significance was assumed when P Ͻ 0.05. All data are presented as means Ϯ SE.
RESULTS
Ghrelin's Role in Neuroprotection After Global Ischemia
Surgery and survival. There were no fatalities from the sham or 2VO procedure after 24 h. There were no significant differences between the groups in core (rectal) temperature at anesthesia, lowest or highest core temperature, or temperature range during surgery (data not shown).
ghrϪ/Ϫ Mice have less hippocampal damage after global ischemia. To assess hippocampal damage after global ischemia, we counted numbers of surviving pyramidal cells in the CA1 and CA2/3 regions. Surviving CA1 cell numbers were reduced significantly by the 2VO at 24 h, but this effect was similar between wt and ghrϪ/Ϫ mice [two-way ANOVA; genotype ϫ surgery; significant effect of surgery: F (3, 28) ϭ 32.19, P Ͻ 0.001; Fig. 1, A and C]. In the CA2/3 region, cell survival was only affected significantly in the wt mice, and the ghrϪ/Ϫ mice had less damage than the wt after the 2VO [significant effect of surgery: F (3, 28) ϭ 16.50, P Ͻ 0.001; Fig. 1, B and D] . Interestingly, the area of the hippocampus wherein there were differences in cell survival between the wt and ghrϪ/Ϫ is also a region of significant GHSR expression (Fig. 2) . We see no expression of the GHSR in the CA1 region.
ghrϪ/Ϫ Mice have less cognitive impairment after global ischemia. To determine whether this difference in hippocampal cell survival is reflected in differences in memory deficit, we investigated performance in novel object-recognition tests for hippocampal-dependent memory. Prior to the 2VO, wt and ghrϪ/Ϫ groups of mice spent more time exploring the new object than the familiar (had discrimination ratios Ͼ0.5), indicative of normal memory. The 2VO significantly affected object recognition [two-way ANOVA; genotype ϫ surgery; significant effect of surgery: F (3, 38) ϭ 6.17, P ϭ 0.017; Fig.  1E ], but the memory deficit was only apparent in the wt mice. Thus wt mice explored the familiar and novel objects to approximately the same degree, indicating that they did not recognize the novel object as new.
ghrϪ/Ϫ Mice have less neuronal degeneration but more apoptosis after global ischemia. To investigate further the extent of the damage induced by the 2VO, we also counted numbers of degenerating cells in the hippocampus, i.e., those positive for Fluoro-Jade. As expected, we found no evidence of degenerating cells in the sham-treated mice (Fig. 3, A-D) . The 2VO caused significant cell degeneration in the CA2/3 [twoway ANOVA; genotype ϫ surgery; significant genotype ϫ surgery interaction: F (3, 28) ϭ 5.30, P ϭ 0.03; Fig. 3 , B and D], and consistent with greater pyramidal cell survival in ghrϪ/Ϫ compared with wt mice, there were significantly fewer degenerating cells after 2VO in this region in the ghrϪ/Ϫ.
To determine the extent of apoptosis after the 2VO, we examined numbers of CA1 and CA2/3 hippocampal cells (DAPI) positive for caspase-3. In both regions, some caspase-3-positive cells were evident, even under sham conditions. In the CA1 region, the 2VO increased apoptosis to a similar degree in both wt and ghrϪ/Ϫ mice [significant effect of surgery: F (3, 28) ϭ 172.32, P Ͻ 0.001; Fig. 3 , E and G]. In the CA2/3 region, the 2VO increased apoptotic cell numbers in both groups, but this effect was exacerbated in the ghrϪ/Ϫ [significant genotype ϫ surgery interaction: F (3, 28) ϭ 80.25, P Ͻ 0.001; Fig. 3, F and H] .
ghrϪ/Ϫ Mice have increased numbers of microglia and astrocytes after global ischemia. To investigate potential differences between wt and ghrϪ/Ϫ mice in the neuroinflammatory response to global ischemia, we examined microglial activation in the hippocampus. In the CA1 region, the 2VO increased total numbers of microglia (cells positive for Iba-1) in both groups [two-way ANOVA; genotype ϫ surgery; significant effect of surgery: F (3, 28) ϭ 55.86, P Ͻ 0.001; genotype: F (3, 28) ϭ 10.84, P ϭ 0.003; Fig. 4C ], but this effect was significantly more pronounced in the ghrϪ/Ϫ mice. Furthermore, the ghrϪ/Ϫ mice had significantly more activated microglia in the CA1 than wt [significant effect of surgery: F (3, 28) ϭ 28.49, P Ͻ 0.001; Fig. 4 , B and C]. In the CA2/3, the 2VO significantly increased total number [significant effect of surgery: F (3, 28) ϭ 17.97, P Ͻ 0.001] and number activated [significant effect of surgery: F (3, 28) ϭ 33.29, P Ͻ 0.001], but the changes were not different between the wt and ghrϪ/Ϫ (Fig. 4, D and E) .
Consistent with a proinflammatory effect of the 2VO, there were significantly more astrocytes (GFAP-positive cells) after the 2VO compared with sham in both groups. In the CA2/3 region, there were also significantly more astrocytes after the 2VO in the ghrϪ/Ϫ compared with wt [CA1, significant effect of surgery: F (3, 28) ϭ 22.74, P Ͻ 0.001; CA2/3, significant genotype ϫ surgery interaction: F (3, 28) ϭ 11.80, P ϭ 0.002; Fig. 4, F and G] .
ghrϪ/Ϫ Mice have reduced core temperature dysregulation after global ischemia. In the hours immediately following the 2VO surgery, both groups were hypothermic, with core temperatures in the wt dropping to ϳ32.6 Ϯ 0.8°C (Fig. 4H) . The wt continued to show hypothermia relative to the ghrϪ/Ϫ for the 24 h after surgery when the areas under the curve were analyzed [t (21) ϭ 2.28, P ϭ 0.033; Fig. 4, H and I ]. An ANOVA, with time as the repeated measure and genotype as the between factor, revealed a significant interaction between time and genotype for the first 8 h after surgery [F (1, 42) (1, 94) 
ghrϪ/Ϫ Mice have improved long-term survival after global ischemia. Our data indicated that endogenous ghrelin is not likely to be neuroprotective in the first 24 h after 2VO but may instead be detrimental to outcomes after global ischemia. We thus examined survival in a second cohort for 7 days after the 2VO. Of the 11 wt and 12 ghrϪ/Ϫ that had the 2VO, five wt (45%) and 11 ghrϪ/Ϫ (92%) survived for 7 days (Fig. 5) . Body weight loss among survivors in this cohort was not significantly different after 24 h or at 6 days.
DISCUSSION
Previous studies have reported that administration of exogenous ghrelin is protective in animal models of neurodegenerative injury, raising the possibility that endogenous ghrelin may normally protect the brain against ischemic stroke. In this study, however, we present direct evidence that mice lacking endogenous ghrelin have improvements in a number of parameters after global cerebral ischemia, indicating that endogenous ghrelin may, in fact, contribute to neuronal injury and associated cognitive impairment after stroke. Specifically, we found that mice did better in terms of memory, hippocampal cell survival, and inflammation/temperature regulation in the short term (24 h), after global cerebral ischemia-reperfusion if they did not have endogenous ghrelin (i.e., in ghrϪ/Ϫ), than mice with normal ghrelin levels. Possibly, the most striking observation was that Ͼ50% of the wt mice died during the week following the 2VO, whereas all but one of the ghrϪ/Ϫ mice survived, indicating that a lack of endogenous ghrelin significantly improves long-term survival in this model of ischemia.
Given that administration of exogenous ghrelin is protective in models of focal ischemia (e.g., middle cerebral artery occlusion) and in other models of neurodegeneration, we hypothesized originally that endogenous ghrelin would be neuroprotective in this E: discrimination ratios, illustrating time spent exploring the novel object over total time spent exploring the novel and familiar objects in a novel object-recognition test of hippocampal-dependent memory. wt ϭ wild-type; ghrϪ/Ϫ ϭ ghrelin knockout; 2VO ϭ 2-vessel occlusion; *P Ͻ 0.05. model of global ischemia. Somewhat surprisingly, we found that ghrϪ/Ϫ mice had more surviving neuronal cells in the CA2/3 region of the hippocampus and fewer degenerating cells, whereas the CA1 region appeared to be unaffected by a lack of endogenous ghrelin. Furthermore, this pattern of cell survival and neurodegeneration in the ghrϪ/Ϫ mice appeared to correlate with expression of GHSR, the ghrelin receptor, which was localized to the CA2/3 but not the CA1 region of the hippocampus, an expression pattern that accords with similar findings from the rat (26) and mouse (79) . This pattern of cell survival and neurodegeneration is also consistent with our finding that ghrϪ/Ϫ mice have less memory impairment after global ischemia. The wt mice had a significant deficit in the novel object-recognition task after the 2VO, essentially unable to recognize the new object as novel, whereas the ghrϪ/Ϫ behaved similarly to sham-treated mice. Evidence suggests that the CA1 region is primarily responsible for forming associations among temporally related stimuli, for example, when one is required to remember a sequence of events (35), and is less important for associations among stimuli in general. The CA3 region, on the other hand, is likely to be responsible for matching incoming (novel) information from the entorhinal cortex with information stored from previous experiences. It is therefore important in processing novel information, and CA3 lesions can affect novel object recognition (35). Our data are thus consistent with more CA2/3 damage in the wt mice causing the memory deficits in the novel object-recognition task.
Several tests of cognitive function have shown that exogenous ghrelin improves memory (19, 29) . Likewise, impaired ghrelin signaling, either in ghrϪ/Ϫ animals or GHSR knockout (GHSRϪ/Ϫ), is linked to memory deficits (2, 19) . We should note that in contrast to these findings (19) , our ghrϪ/Ϫ mice had no deficits in novel object recognition under basal (sham) conditions. We have also seen no differences between wt and ghrϪ/Ϫ mice in extinction freezing as a percentage of conditioning in a contextual fear-conditioning test (unpublished observations). Diano and colleagues (19) have shown that ghrϪ/Ϫ mice performed less well than wt in a novel objectrecognition test, 4 h after the initial acquisition trial. In our experiment, performance was not different between the wt and ghrϪ/Ϫ sham groups under similar conditions, except that our recognition tests took place 30 min after the acquisition trial. In preliminary trials, we identified that wt mice performed poorly in the novel object-recognition test with an intertrial interval of 1 h; i.e., their novel object exploration was not greater than that of the familiar object, indicating no recollection. The reasons for the differences between our results and those of Diano and colleagues (19) are not immediately apparent. However, it is possible that our findings reflect a limited role for ghrelin in short-term memory under basal conditions, whereas those of Diano et al. (19) reflect an important role for the peptide in storage of longer-term memories. This possibility is supported by findings of Carlini et al. (5) , where ghrelin administered directly into the rat hippocampus improves long-term memory without altering short-term memory or memory retrieval. Another factor that may account for these differences is genetic background. Our mice, although originally on a 129sv/C57/ Bl6J background from the same source as Diano et al. (19) , were backcrossed at least 10 times onto a pure C57/Bl6J strain. Our breeding pairs were generated from heterozygotes of these backcrosses, and so our ghrϪ/Ϫ and wt mice have the same genetic background, except for deletion of the ghrelin gene in the ghrϪ/Ϫ. Differences in the background strain used may therefore have contributed to differences in wt and ghrϪ/Ϫ behaviors seen between laboratories. Indeed, differences in long-term potentiation formation and behavioral indices of memory have been demonstrated among C57/Bl6J and 129Sv mice, which possibly account for some of the findings of earlier studies (47, 73) . It should also be noted that whereas the majority of studies has shown a beneficial effect of ghrelin on memory, this result is not ubiquitous. For instance, GHSRϪ/Ϫ mice have deficits in contextual memory but also perform better than their wt counterparts in the Morris water maze test for spatial memory (2) . Exogenous ghrelin application has also been shown to have no effect on short-term memory or retrieval in rats and no effect on memory consolidation in humans (5, 20) .
Previous studies have shown that ghrelin can suppress caspasedependent apoptosis in other models of neurodegeneration, including focal ischemia (3, 6, 8, 28, 40, 43) . Consistent with these studies but in contrast to our cell-survival, degeneration, and memory-function experiments, we found that ghrϪ/Ϫ mice had a modestly but significantly elevated number of apoptotic neurons in the CA2/3 region of the hippocampus compared with wt, 24 h after global ischemia. Thus it would appear that endogenous ghrelin normally serves to limit apoptotic pathways after global ischemia. This idea is supported by previous findings that ghrϪ/Ϫ mice have a greater loss of striatal tyrosine hydroxylase cells and dopamine content after an injection of MPTP to model PD. The mechanism of cell death at this dose of MPTP is primarily apoptosis-the MPTP interfering with the electron transport chain within the mitochondria (3, 21) . Apoptosis is a mechanism of cell death that is regulated by specific signaling pathways. This specific cell "suicide" is in contrast to necrosis, where the entire cell fails to function, due to insufficient ATP (77) . In apoptosis, the expression of proapoptotic B cell lymphoma 2 (Bcl2)-associated X protein (BAX) is activated and antiapoptotic Bcl2 suppressed. With the activation of BAX comes increased cytochrome C release from the mitochondria, leading to activation of caspase-3 and cell death (16, 48, 57, 78) . Exogenous ghrelin administration is able to improve the Bcl2/BAX ratio and inhibit caspase activation to prevent the cell undergoing apoptosis (28, 31, 40). In focal ischemia, PD, and AD, the principal mode of cell death in the ischemic penumbra (focal ischemia) and damaged neurons (PD, AD) is via apoptosis (4). Thus there is significant potential for ghrelin to improve overall cell survival and outcomes in these conditions. In global cerebral ischemia, as was used in this study, the principal mode of cell death is necrosis (11) . A single study has shown that ghrelin can protect against the necrosis that is caused by persistent ischemia in musculoskeletal tissues, but in this case, it does so by upregulating inducible nitric oxide synthase, which in turn, improves the local microcirculation (54) . To the best of our knowledge, no study has tested whether ghrelin can directly influence necrotic cell death after cerebral ischemia. This suggestion that global cerebral ischemia involves primarily a cell-death mechanism, against which ghrelin may not be useful, might explain why ghrϪ/Ϫ mice are not worse off than wt after 2VO, although they are worse off after MPTP injection (3). Ghrelin's role in inflammation may provide a further explanation. Ghrelin is known to be anti-inflammatory (22). Endogenous ghrelin can suppress the proinflammatory cytokine profile associated with sepsis (76), nonalcoholic fatty liver disease (38), burn-induced multiple organ injury (56) , and ischemia (6) . It also reduces microglial activation and astrocyte proliferation (37, 45) and can attenuate the febrile responses to immune challenge (60) . Consistent with ghrelin's known antiinflammatory roles, we found more microglia in total in the hippocampus, and more of these were activated in the ghrϪ/Ϫ mice after the 2VO compared with wt. There were also more astrocytes in the hippocampus after the 2VO. This apparently proinflammatory profile in our ghrϪ/Ϫ mice may therefore reflect the beneficial function of a certain degree of inflammation after 2VO.
Microglial activation is known to be an essential component of the repair process following cerebral ischemia (72) , and the outcomes in our wt mice seem to indicate that its suppression may be detrimental. Microglia are known to have a dual role in response to injury (41) and can clearly be detrimental to recovery and cell survival if chronically activated (24). However, microglia are also protective, particularly in the short term (24). In response to ATP and other factors released by injured cells, microglia become activated and migrate toward the injury site (18, 39) . Once there, microglia form a physical barrier between injured and healthy tissue (18) . They also phagocytose cytotoxic debris, produce anti-inflammatory cytokines, and contribute to tissue repair and extracellular matrix remodeling (41, 69). It is possible that the increased microglial activation that we see in ghrϪ/Ϫ mice contributes to a beneficial effect to make these mice better off after the global ischemia than the wt.
A further interesting observation from our data is that the wt mice remained cooler than the ghrϪ/Ϫ in their core body temperatures for the 24 h after the 2VO. Whereas cooler core temperatures are known to be neuroprotective (10, 13, 14) , it seems that the hypothermia that we see in the wt may be rather too extreme to be adaptive. The protective effects of hypothermia have been seen with as little as 1°C reduction in core temperature immediately prior to and during the ischemia (55) . Furthermore, hypothermia to the order of 33°C (such as is seen here in the wt at 24 h) is often fatal (70) . Ghrelin is known to have a role in temperature regulation, attenuating fever in response to an immune challenge (60) . It is possible that this otherwise physiologically adaptive action of ghrelin in temperature regulation becomes dysregulated in cases of 2VO. This excessive hypothermia could become so metabolically expensive as to threaten the survival of the animal.
Another possible explanation for our results is that ghrelin enhances cell death through enhanced glutamatergic neurotransmission, which is necessary for ghrelin's effects on mesolimbic dopaminergic reward pathways (30). Ghrelin may also stimulate memory formation in a glutamate-dependent manner (19) ; however, excessive glutamate release can lead to excitotoxicity (42) , perhaps explaining why our wt mice appear to be worse off after the 2VO. This possibility would not explain, however, why the results from our study seem to contrast with those that have used exogenous ghrelin treatment to improve outcomes after ischemia.
As outlined above, our data point toward a deleterious role for endogenous ghrelin after global cerebral ischemia. One other potential explanation for why ghrϪ/Ϫ mice appear to be protected against cerebral ischemia may be related to GHSR and the fact that it is known to be highly, constitutively active, at least in vitro. Indeed, it signals at ϳ50% of its maximal capacity in the absence of ghrelin (51) . Even in the absence of ghrelin, this constitutive activity can result in the stimulation of ghrelin-signaling pathways (51) . It is possible, but not yet tested, that in the complete absence of ghrelin, there may be increased expression of the GHSR and/or increased constitutive activity that activates the usual neuroprotective ghrelin pathways. Evidence of the importance of this receptor in degeneration in this model lies in our observation that the principal area where cell death was prevented in ghrϪ/Ϫ relative to wt-the CA2/3 region-is one of significant GHSR expression. Despite in vitro evidence that the GHSR may be highly, constitutively active, the physiological relevance of this activity has not yet been fully demonstrated. However, there is some evidence in the literature that it may have a physiological role. For example, humans with a mis-sense mutation in the GHSR have less GHSR constitutive activity, and this is linked to less growth-hormone release and short stature (49) . Furthermore, GHSRϪ/Ϫ mice have been shown to have a higher threshold to a pilocarpine seizure than wt mice, an effect that is mimicked by an inverse agonist for GHSR, indicating that ghrelin normally reduces constitutive activity of the receptor to attenuate seizure activity (52) . Very recent evidence indicates that GHSR1a expression is also capable of modifying additional signaling pathways; in particular, signaling of the dopamine D2 receptor (DRD2). Thus GHSR1a forms a heteromer with DRD2 that can independently modify feeding behavior in the absence of ghrelin (33). It is possible that this interaction is also modified in our ghrϪ/Ϫ mice. Whether ghrelin is produced in the brain has been somewhat controversial, and recent evidence from our group suggests that it is not produced centrally in significant amounts (25). Stomach-derived ghrelin can cross the blood-brain barrier and is likely to enter the brain to influence hippocampal function (7, 19, 67) , but independent activity of the receptor could also contribute to an apparent effect of the ghrelin pathway in the absence of ghrelin production in the brain.
Perspectives and Significance
Ghrelin is known to have neuroprotective effects in several models of neurodegenerative disease. The results from our study show, however, that mice lacking endogenous ghrelin are actually better off in a number of parameters after global ischemia than those with normal ghrelin levels. We have shown that memory, cell survival, and mortality are worse in wt mice compared with ghrϪ/Ϫ. We speculate that these findings reflect the mode of cell death in global ischemiaprimarily necrotic-against which ghrelin is not protective. There may also be a protective role for constitutive activity of the GHSR that is elevated in the absence of ghrelin. Why the absence of endogenous ghrelin appears to be protective after 2VO is yet unclear. However, the message remains that further research is essential before we can apply ghrelin treatments to neurodegenerative insults in the clinic. 
